- Home
- VMAR vs GTBP Comparison
VMAR vs GTBP Comparison
Compare VMAR & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- GTBP
- Stock Information
- Founded
- VMAR 1995
- GTBP 1965
- Country
- VMAR Canada
- GTBP United States
- Employees
- VMAR N/A
- GTBP N/A
- Industry
- VMAR Marine Transportation
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- GTBP Health Care
- Exchange
- VMAR Nasdaq
- GTBP Nasdaq
- Market Cap
- VMAR 5.9M
- GTBP 5.5M
- IPO Year
- VMAR 2020
- GTBP N/A
- Fundamental
- Price
- VMAR $1.94
- GTBP $1.34
- Analyst Decision
- VMAR
- GTBP Strong Buy
- Analyst Count
- VMAR 0
- GTBP 1
- Target Price
- VMAR N/A
- GTBP $11.00
- AVG Volume (30 Days)
- VMAR 1.3M
- GTBP 84.3K
- Earning Date
- VMAR 07-11-2025
- GTBP 08-14-2025
- Dividend Yield
- VMAR N/A
- GTBP N/A
- EPS Growth
- VMAR N/A
- GTBP N/A
- EPS
- VMAR N/A
- GTBP N/A
- Revenue
- VMAR $1,128,568.00
- GTBP N/A
- Revenue This Year
- VMAR N/A
- GTBP N/A
- Revenue Next Year
- VMAR $264.29
- GTBP N/A
- P/E Ratio
- VMAR N/A
- GTBP N/A
- Revenue Growth
- VMAR N/A
- GTBP N/A
- 52 Week Low
- VMAR $1.86
- GTBP $0.96
- 52 Week High
- VMAR $658.67
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- VMAR 14.50
- GTBP 23.00
- Support Level
- VMAR $4.87
- GTBP $1.68
- Resistance Level
- VMAR $5.17
- GTBP $1.89
- Average True Range (ATR)
- VMAR 0.40
- GTBP 0.15
- MACD
- VMAR -0.31
- GTBP -0.02
- Stochastic Oscillator
- VMAR 1.85
- GTBP 33.04
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.